Cozad Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,163
Closed -$743K 384
2023
Q1
$743K Buy
7,163
+1,071
+18% +$119K 0.1% 197
2022
Q4
$703K Buy
6,092
+1,036
+20% +$121K 0.1% 202
2022
Q3
$548K Buy
+5,056
New +$724K 0.09% 207

Other funds holding MED

Cozad Asset Management's MED Position: Q2 2023 in Review

Cozad Asset Management sold out of Medifast (MED) in Q2 2023, closing a stake of 7,163 shares — an estimated $743K sold.

Cozad Asset Management first reported a position in MED in Q3 2022 and held it in 3 quarters. The position peaked at $743K in Q1 2023. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • Cozad Asset Management reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • Cozad Asset Management sold 7,163 Medifast shares in Q2 2023, an estimated $743K.
  • Cozad Asset Management first reported a position in Medifast in Q3 2022 and held it in 3 quarters.
  • Cozad Asset Management's Medifast position peaked at $743K in Q1 2023.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Cozad Asset Management's 13F filing for Q2 2023, filed 26 Jul 2023.